Centralised versus decentralised manufacturing and the delivery of healthcare products: A United Kingdom exemplar
Open Access
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Cytotherapy
- Vol. 20 (6) , 873-890
Abstract
No abstract availableKeywords
Funding Information
- Engineering and Physical Sciences Research Council (EPSRC) Engineering Tissue Engineering and Regenerative Medicine (ETERM) Landscape Fellowship (EP/I017801/1)
- EPSRC Fellowships in Manufacturing (EP/K037099/1)
This publication has 22 references indexed in Scilit:
- A potentially scalable method for the harvesting of hMSCs from microcarriersBiochemical Engineering Journal, 2014
- An analysis of supply chain strategies in the regenerative medicine industry—Implications for future developmentInternational Journal of Production Economics, 2014
- Cell Therapy Companies Make Strong Progress from October 2012 to March 2013 Amid Mixed Stock Market SentimentCell Stem Cell, 2013
- Culture of human mesenchymal stem cells on microcarriers in a 5 l stirred-tank bioreactorBiotechnology Letters, 2013
- Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industryCytotherapy, 2013
- Decentralized manufacturing systems review: challenges and outlookLogistics Research, 2012
- Towards energy and resource efficient manufacturing: A processes and systems approachCIRP Annals, 2012
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate CancerNew England Journal of Medicine, 2010
- The sustainable agenda and energy efficiencyInternational Journal of Physical Distribution & Logistics Management, 2010
- Services for distribution of tissue engineering products and therapiesInternational Journal of Productivity and Performance Management, 2008